RecruitingNCT01106794

Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma


Sponsor

Children's National Research Institute

Enrollment

100 participants

Start Date

Apr 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.


Eligibility

Max Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study collects and analyzes tumor samples from patients with brainstem gliomas (brain tumors located in the brainstem) to understand the molecular makeup of these cancers and find better treatment targets. **You may be eligible if...** - You have been diagnosed with diffuse intrinsic pontine glioma (DIPG), a type of brainstem tumor, at any age - You have another type of high-grade (aggressive) glioma originating in the brainstem - You have a low-grade (slower-growing) focal glioma of the brainstem **You may NOT be eligible if...** - Your brain tumor started outside the brainstem (even if it spread there) - You have a brainstem tumor of a different cell type (e.g., primitive neuroectodermal tumor) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Children's National Medical Center

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01106794


Related Trials